Sox proteins in melanocyte development and melanoma

Pigment Cell and Melanoma Research

Volumn 23, Issue 4, 2010, Pages 496-513

  Harris, Melissa L ^a   Baxter, Laura L ^a   Loftus, Stacie K ^a   Pavan, William J ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

adult; development; melanocyte; melanoma; regulation; sox; transcription factor

Indexed keywords

TRANSCRIPTION FACTOR SOX10; TRANSCRIPTION FACTOR SOX18; TRANSCRIPTION FACTOR SOX5; TRANSCRIPTION FACTOR SOX9;

CELL CYCLE; CELL FUNCTION; CELL MATURATION; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; MELANOCYTE; MELANOGENESIS; MELANOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW;

ANIMALS; HUMANS; MELANOCYTES; MELANOMA; SOX TRANSCRIPTION FACTORS;

EID: 77954727828     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2010.00711.x     Document Type: Review

References (145)

1. Adameyko, I., Lallemend, F., Aquino, J.B. et al. (2009). Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin. Cell 139, 366 379.
2. Antonellis, A., Bennett, W.R., Menheniott, T.R., Prasad, A.B., Lee-Lin, S.Q., Green, E.D., Paisley, D., Kelsh, R.N., Pavan, W.J. Ward, A. (2006). Deletion of long-range sequences at Sox10 compromises developmental expression in a mouse model of Waardenburg-Shah (WS4) syndrome. Hum. Mol. Genet. 15, 259 271.
3. Antonellis, A., Huynh, J.L., Lee-Lin, S.Q. et al. (2008). Identification of neural crest and glial enhancers at the mouse Sox10 locus through transgenesis in zebrafish. PLoS Genet. 4, e1000174.
4. Aoki, Y., Saint-Germain, N., Gyda, M., Magner-Fink, E., Lee, Y.H., Credidio, C. Saint-Jeannet, J.P. (2003). Sox10 regulates the development of neural crest-derived melanocytes in Xenopus. Dev. Biol. 259, 19 33.
5. Bakos, R.M., Maier, T., Besch, R., Mestel, D.S., Ruzicka, T., Sturm, R.A. Berking, C. (2009). Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma. Exp. Dermatol. doi :.
6. Barnett, C.P., Mendoza-Londono, R., Blaser, S., Gillis, J., Dupuis, L., Levin, A.V., Chiang, P.W., Spector, E. Reardon, W. (2009). Aplasia of cochlear nerves and olfactory bulbs in association with SOX10 mutation. Am. J. Med. Genet. A. 149A, 431 436.
7. Belmadani, A., Jung, H., Ren, D. Miller, R.J. (2009). The chemokine SDF-1/CXCL12 regulates the migration of melanocyte progenitors in mouse hair follicles. Differentiation 77, 395 411.
8. Blochin, E. Nonaka, D. (2009). Diagnostic value of Sox10 immunohistochemical staining for the detection of metastatic melanoma in sentinel lymph nodes. Histopathology 55, 626 628.
9. Bondurand, N., Kuhlbrodt, K., Pingault, V. et al. (1999). A molecular analysis of the yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies. Hum. Mol. Genet. 8, 1785 1789.
10. Bondurand, N., Pingault, V., Goerich, D.E., Lemort, N., Sock, E., Caignec, C.L., Wegner, M. Goossens, M. (2000). Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum. Mol. Genet. 9, 1907 1917.
11. Bondurand, N., Girard, M., Pingault, V., Lemort, N., Dubourg, O. Goossens, M. (2001). Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum. Mol. Genet. 10, 2783 2795.
12. Bondurand, N., Dastot-Le Moal, F., Stanchina, L. et al. (2007). Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4. Am. J. Hum. Genet. 81, 1169 1185.
13. Botchkareva, N.V., Botchkarev, V.A. Gilchrest, B.A. (2003). Fate of melanocytes during development of the hair follicle pigmentary unit. J. Investig. Dermatol. Symp. Proc. 8, 76 79.
14. Bowles, J., Schepers, G. Koopman, P. (2000). Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev. Biol. 227, 239 255.
15. Britsch, S., Goerich, D.E., Riethmacher, D., Peirano, R.I., Rossner, M., Nave, K.A., Birchmeier, C. Wegner, M. (2001). The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 15, 66 78.
16. Buac, K., Watkins-Chow, D.E., Loftus, S.K., Larson, D.M., Incao, A., Gibney, G. Pavan, W.J. (2008). A Sox10 expression screen identifies an amino acid essential for Erbb3 function. PLoS Genet. 4, e1000177.
17. Carney, T.J., Dutton, K.A., Greenhill, E., Delfino-Machin, M., Dufourcq, P., Blader, P. Kelsh, R.N. (2006). A direct role for Sox10 in specification of neural crest-derived sensory neurons. Development 133, 4619 4630.
18. Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K.S., Testori, A., Larue, L. Goding, C.R. (2006). Mitf regulation of dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20, 3426 3439.
19. Cheung, M. Briscoe, J. (2003). Neural crest development is regulated by the transcription factor Sox9. Development 130, 5681 5693.
20. Cheung, M., Chaboissier, M.-C., Mynett, A., Hirst, E., Schedl, A. Briscoe, J. (2005). The transcriptional control of trunk neural crest induction, survival, and delamination. Dev. Cell 8, 179 192.
21. Choi, Y.J., Yoon, T.J. Lee, Y.H. (2008). Changing expression of the genes related to human hair graying. Eur. J. Dermatol. 18, 397 399.
22. Commo, S., Gaillard, O., Thibaut, S. Bernard, B.A. (2004). Absence of TRP-2 in melanogenic melanocytes of human hair. Pigment Cell Res. 17, 488 497.
23. Cook, A.L., Donatien, P.D., Smith, A.G., Murphy, M., Jones, M.K., Herlyn, M., Bennett, D.C., Leonard, J.H. Sturm, R.A. (2003). Human melanoblasts in culture: expression of BRN2 and synergistic regulation by fibroblast growth factor-2, stem cell factor, and endothelin-3. J. Invest. Dermatol. 121, 1150 1159.
24. Cook, A.L., Smith, A.G., Smit, D.J., Leonard, J.H. Sturm, R.A. (2005). Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro. Exp. Cell Res. 308, 222 235.
25. Cronin, J., Wunderlich, J., Loftus, S.K. et al. (2009). Frequent mutations in the MITF pathway in melanoma. Pigment Cell Melanoma Res. 22, 435 444.
26. Dahlstrand, J., Collins, V.P. Lendahl, U. (1992a). Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res. 52, 5334 5341.
27. Dahlstrand, J., Zimmerman, L.B., McKay, R.D. Lendahl, U. (1992b). Characterization of the human nestin gene reveals a close evolutionary relationship to neurofilaments. J. Cell Sci. 103 (Pt 2 589 597.
28. Deal, K.K., Cantrell, V.A., Chandler, R.L., Saunders, T.L., Mortlock, D.P. Southard-Smith, E.M. (2006). Distant regulatory elements in a Sox10-beta GEO BAC transgene are required for expression of Sox10 in the enteric nervous system and other neural crest-derived tissues. Dev. Dyn. 235, 1413 1432.
29. den Dunnen, J.T. Antonarakis, S.E. (2000). Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum. Mutat. 15, 7 12.
30. Dutton, K.A., Pauliny, A., Lopes, S.S., Elworthy, S., Carney, T.J., Rauch, J., Geisler, R., Haffter, P. Kelsh, R.N. (2001). Zebrafish colourless encodes sox10 and specifies non-ectomesenchymal neural crest fates. Development 128, 4113 4125.
31. Dutton, J.R., Antonellis, A., Carney, T.J., Rodrigues, F.S., Pavan, W.J., Ward, A. Kelsh, R.N. (2008). An evolutionarily conserved intronic region controls the spatiotemporal expression of the transcription factor Sox10. BMC Dev. Biol. 8, 105.
32. Elworthy, S., Lister, J.A., Carney, T.J., Raible, D.W. Kelsh, R.N. (2003). Transcriptional regulation of mitfa accounts for the sox10 requirement in zebrafish melanophore development. Development 130, 2809 2818.
33. Erickson, C.A., Duong, T.D. Tosney, K.W. (1992). Descriptive and experimental analysis of the dispersion of neural crest cells along the dorsolateral path and their entry into ectoderm in the chick embryo. Dev. Biol. 151, 251 272.
34. Flammiger, A., Besch, R., Cook, A.L., Maier, T., Sturm, R.A. Berking, C. (2009). SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells. J. Invest. Dermatol. 129, 945 953.
35. Garraway, L.A., Widlund, H.R., Rubin, M.A., et al. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117 122.
36. Gasca, S., Canizares, J., De Santa Barbara, P., Mejean, C., Poulat, F., Berta, P. Boizet-Bonhoure, B. (2002). A nuclear export signal within the high mobility group domain regulates the nucleocytoplasmic translocation of SOX9 during sexual determination. Proc. Natl Acad. Sci. USA 99, 11199 11204.
37. Ghislain, J. Charnay, P. (2006). Control of myelination in Schwann cells: a Krox20 cis-regulatory element integrates Oct6, Brn2 and Sox10 activities. EMBO Rep. 7, 52 58.
38. Girard, M. Goossens, M. (2006). Sumoylation of the SOX10 transcription factor regulates its transcriptional activity. FEBS Lett. 580, 1635 1641.
39. Gontan, C., Guttler, T., Engelen, E., Demmers, J., Fornerod, M., Grosveld, F.G., Tibboel, D., Gorlich, D., Poot, R.A. Rottier, R.J. (2009). Exportin 4 mediates a novel nuclear import pathway for Sox family transcription factors. J. Cell Biol. 185, 27 34.
40. Guth, S.I. Wegner, M. (2008). Having it both ways: Sox protein function between conservation and innovation. Cell. Mol. Life Sci. 65, 3000 3018.
41. Hakami, R.M., Hou, L., Baxter, L.L., Loftus, S.K., Southard-Smith, E.M., Incao, A., Cheng, J. Pavan, W.J. (2006). Genetic evidence does not support direct regulation of EDNRB by SOX10 in migratory neural crest and the melanocyte lineage. Mech. Dev. 123, 124 134.
42. Harley, V.R., Lovell-Badge, R. Goodfellow, P.N. (1994). Definition of a consensus DNA binding site for SRY. Nucleic Acids Res. 22, 1500 1501.
43. Hasegawa, J., Goto, Y., Murata, H., Takata, M., Saida, T. Imokawa, G. (2008). Downregulated melanogenic paracrine cytokine linkages in hypopigmented palmoplantar skin. Pigment Cell Melanoma Res. 21, 687 699.
44. Hedstrand, H., Ekwall, O., Olsson, M.J. et al. (2001). The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I. J. Biol. Chem. 276, 35390 35395.
45. Herbarth, B., Pingault, V., Bondurand, N., Kuhlbrodt, K., Hermans-Borgmeyer, I., Puliti, A., Lemort, N., Goossens, M. Wegner, M. (1998). Mutation of the Sry-related Sox10 gene in dominant megacolon, a mouse model for human Hirschsprung disease. Proc. Natl. Acad. Sci. USA 95, 5161 5165.
46. Hirobe, T. (1984). Histochemical survey of the distribution of the epidermal melanoblasts and melanocytes in the mouse during fetal and postnatal periods. Anat. Rec. 208, 589 594.
47. Hoek, K.S., Schlegel, N.C., Brafford, P. et al. (2006). Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 19, 290 302.
48. Hoek, K.S., Eichhoff, O.M., Schlegel, N.C., Dobbeling, U., Kobert, N., Schaerer, L., Hemmi, S. Dummer, R. (2008). In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 68, 650 656.
49. Holbrook, K.A., Underwood, R.A., Vogel, A.M., Gown, A.M. Kimball, H. (1989). The appearance, density and distribution of melanocytes in human embryonic and fetal skin revealed by the anti-melanoma monoclonal antibody, HMB-45. Anat. Embryol. (Berl). 180, 443 455.
50. Hong, C.-S. Saint-Jeannet, J.-P. (2005). Sox proteins and neural crest development. Semin. Cell Dev. Biol. 16, 694 703.
51. Hou, L., Arnheiter, H. Pavan, W.J. (2006). Interspecies difference in the regulation of melanocyte development by SOX10 and MITF. Proc. Natl. Acad. Sci. USA 103, 9081 9085.
52. Huber, W.E., Price, E.R., Widlund, H.R., Du, J., Davis, I.J., Wegner, M. Fisher, D.E. (2003). A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes. J. Biol. Chem. 278, 45224 45230.
53. Inoue, K., Tanabe, Y. Lupski, J.R. (1999). Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation. Ann. Neurol. 46, 313 318.
54. Inoue, K., Shilo, K., Boerkoel, C.F., Crowe, C., Sawady, J., Lupski, J.R. Agamanolis, D.P. (2002). Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg-Hirschsprung disease: phenotypes linked by SOX10 mutation. Ann. Neurol. 52, 836 842.
55. Inoue, K., Khajavi, M., Ohyama, T. et al. (2004). Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat. Genet. 36, 361 369.
56. Iso, M., Fukami, M., Horikawa, R., Azuma, N., Kawashiro, N. Ogata, T. (2008). SOX10 mutation in Waardenburg syndrome type II. Am. J. Med. Genet. A. 146A, 2162 2163.
57. Iwamoto, K., Bundo, M., Yamada, K., Takao, H., Iwayama, Y., Yoshikawa, T. Kato, T. (2006). A family-based and case-control association study of SOX10 in schizophrenia. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141B, 477 481.
58. Jiao, Z., Mollaaghababa, R., Pavan, W.J., Antonellis, A., Green, E.D. Hornyak, T.J. (2004). Direct interaction of sox10 with the promoter of murine dopachrome tautomerase (dct) and synergistic activation of dct expression with mitf. Pigment Cell Res. 17, 352 362.
59. Kamachi, Y., Uchikawa, M. Kondoh, H. (2000). Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet. 16, 182 187.
60. Kellerer, S., Schreiner, S., Stolt, C.C., Scholz, S., Bosl, M.R. Wegner, M. (2006). Replacement of the Sox10 transcription factor by Sox8 reveals incomplete functional equivalence. Development 133, 2875 2886.
61. Kelsh, R.N. Eisen, J.S. (2000). The zebrafish colourless gene regulates development of non-ectomesenchymal neural crest derivatives. Development 127, 515 525.
62. Kelsh, R.N., Harris, M.L., Colanesi, S. Erickson, C.A. (2009). Stripes and belly-spots - a review of pigment cell morphogenesis in vertebrates. Semin. Cell Dev. Biol. 20, 90 104.
63. Kiefer, J. (2007). Back to basics: Sox genes. Dev. Dyn. 236, 2356 2366.
64. Kim, J., Lo, L., Dormand, E. Anderson, D.J. (2003). SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells. Neuron 38, 17 31.
65. Kondoh, H. Kamachi, Y. (2009). SOX-partner code for cell specification: regulatory target selection and underlying molecular mechanisms. Int. J. Biochem. Cell Biol. 42, 391 399.
66. Krahl, D. Sellheyer, K. (2009). Sox9, more than a marker of the outer root sheath: spatiotemporal expression pattern during human cutaneous embryogenesis. J. Cutan. Pathol. 37, 350 356.
67. Kuhlbrodt, K., Herbarth, B., Sock, E., Hermans-Borgmeyer, I. Wegner, M. (1998). Sox10, a novel transcriptional modulator in glial cells. J. Neurosci. 18, 237 250.
68. Lane, P.W. Liu, H.M. (1984). Association of megacolon with a new dominant spotting gene (Dom) in the mouse. J. Hered. 75, 435 439.
69. Lang, D. Epstein, J.A. (2003). Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. Hum. Mol. Genet. 12, 937 945.
70. Lang, D., Lu, M., Huang, L., Engleka, K., Zhang, M., Chu, E., Lipner, S., Skoultchi, A., Millar, S. Epstein, J. (2005). Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 433, 884 887.
71. Le Douarin, N.M. Kalcheim, C. (1999). The Neural Crest, 2nd edn
72. LeBlanc, S.E., Ward, R.M. Svaren, J. (2007). Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10. Mol. Cell. Biol. 27, 3521 3529.
73. Lee, M., Goodall, J., Verastegui, C., Ballotti, R. Goding, C.R. (2000). Direct regulation of the microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2. J. Biol. Chem. 275, 37978 37983.
74. Lee, K.E., Nam, S., Cho, E.A., Seong, I., Limb, J.K., Lee, S. Kim, J. (2008). Identification of direct regulatory targets of the transcription factor Sox10 based on function and conservation. BMC Genomics 9, 408.
75. Lister, J.A., Robertson, C.P., Lepage, T., Johnson, S.L. Raible, D.W. (1999). nacre encodes a zebrafish microphthalmia-related protein that regulates neural-crest-derived pigment cell fate. Development 126, 3757 3767.
76. Ludwig, A., Rehberg, S. Wegner, M. (2004). Melanocyte-specific expression of dopachrome tautomerase is dependent on synergistic gene activation by the Sox10 and Mitf transcription factors. FEBS Lett. 556, 236 244.
77. Malki, S., Nef, S., Notarnicola, C., Thevenet, L., Gasca, S., Mejean, C., Berta, P., Poulat, F. Boizet-Bonhoure, B. (2005). Prostaglandin D2 induces nuclear import of the sex-determining factor SOX9 via its cAMP-PKA phosphorylation. EMBO J. 24, 1798 1809.
78. Matera, I., Watkins-Chow, D.E., Loftus, S.K., Hou, L., Incao, A., Silver, D.L., Rivas, C., Elliott, E.C., Baxter, L.L. Pavan, W.J. (2008). A sensitized mutagenesis screen identifies Gli3 as a modifier of Sox10 neurocristopathy. Hum. Mol. Genet. 17, 2118 2131.
79. Mayer, T.C. (1973). The migratory pathway of neural crest cells into the skin of mouse embryos. Dev. Biol. 34, 39 46.
80. McKeown, S.J., Lee, V.M., Bronner-Fraser, M., Newgreen, D.F. Farlie, P.G. (2005). Sox10 overexpression induces neural crest-like cells from all dorsoventral levels of the neural tube but inhibits differentiation. Dev. Dyn. 233, 430 444.
81. Morais da Silva, S., Hacker, A., Harley, V., Goodfellow, P., Swain, A. Lovell-Badge, R. (1996). Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nat. Genet. 14, 62 68.
82. Mori-Akiyama, Y., Akiyama, H., Rowitch, D.H. de Crombrugghe, B. (2003). Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest. Proc. Natl. Acad. Sci. USA 100, 9360 9365.
83. Morin, M., Vinuela, A., Rivera, T., Villamar, M., Moreno-Pelayo, M.A., Moreno, F. del Castillo, I. (2008). A de novo missense mutation in the gene encoding the SOX10 transcription factor in a Spanish sporadic case of Waardenburg syndrome type IV. Am. J. Med. Genet. A. 146A, 1032 1037.
84. Mou, Z., Tapper, A.R. Gardner, P.D. (2009). The armadillo-repeat- containing protein, ARMCX3, physically and functionally interacts with the developmental regulatory factor Sox10. J. Biol. Chem. 284, 13629 13640.
85. Murisier, F., Guichard, S. Beermann, F. (2006). A conserved transcriptional enhancer that specifies Tyrp1 expression to melanocytes. Dev. Biol. 298, 644 655.
86. Murisier, F., Guichard, S. Beermann, F. (2007). The tyrosinase enhancer is activated by Sox10 and Mitf in mouse melanocytes. Pigment Cell Res. 20, 173 184.
87. Nakayama, A., Nguyen, M.T., Chen, C.C., Opdecamp, K., Hodgkinson, C.A. Arnheiter, H. (1998). Mutations in microphthalmia, the mouse homolog of the human deafness gene MITF, affect neuroepithelial and neural crest-derived melanocytes differently. Mech. Dev. 70, 155 166.
88. Nishimura, E.K., Jordan, S.A., Oshima, H., Yoshida, H., Osawa, M., Moriyama, M., Jackson, I.J., Barrandon, Y., Miyachi, Y. Nishikawa, S. (2002). Dominant role of the niche in melanocyte stem-cell fate determination. Nature 416, 854 860.
89. Opdecamp, K., Nakayama, A., Nguyen, M.T., Hodgkinson, C.A., Pavan, W.J. Arnheiter, H. (1997). Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor. Development 124, 2377 2386.
90. Osawa, M., Egawa, G., Mak, S.S., Moriyama, M., Freter, R., Yonetani, S., Beermann, F. Nishikawa, S. (2005). Molecular characterization of melanocyte stem cells in their niche. Development 132, 5589 5599.
91. Paratore, C., Goerich, D.E., Suter, U., Wegner, M. Sommer, L. (2001). Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. Development 128, 3949 3961.
92. Passeron, T., Valencia, J.C., Bertolotto, C., Hoashi, T., Le Pape, E., Takahashi, K., Ballotti, R. Hearing, V.J. (2007). SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation. Proc. Natl. Acad. Sci. USA 104, 13984 13989.
93. Passeron, T., Valencia, J.C., Namiki, T., Vieira, W.D., Passeron, H., Miyamura, Y. Hearing, V.J. (2009). Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid. J. Clin. Invest. 119, 954 963.
94. Peirano, R.I. Wegner, M. (2000). The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences. Nucleic Acids Res. 28, 3047 3055.
95. Pennisi, D., Bowles, J., Nagy, A., Muscat, G. Koopman, P. (2000). Mice null for sox18 are viable and display a mild coat defect. Mol. Cell. Biol. 20, 9331 9336.
96. Pingault, V., Bondurand, N., Kuhlbrodt, K. et al. (1998). SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat. Genet. 18, 171 173.
97. Pingault, V., Guiochon-Mantel, A., Bondurand, N., Faure, C., Lacroix, C., Lyonnet, S., Goossens, M. Landrieu, P. (2000). Peripheral neuropathy with hypomyelination, chronic intestinal pseudo-obstruction and deafness: a developmental "neural crest syndrome" related to a SOX10 mutation. Ann. Neurol. 48, 671 676.
98. Pingault, V., Girard, M., Bondurand, N., Dorkins, H., Van Maldergem, L., Mowat, D., Shimotake, T., Verma, I., Baumann, C. Goossens, M. (2002). SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism. Hum. Genet. 111, 198 206.
99. Pingault, V., Ente, D., Dastot-Le Moal, F., Goossens, M., Marlin, S. Bondurand, N. (2010). Review and update of mutations causing Waardenburg syndrome. Hum. Mutat. 31, 391 406.
100. Potterf, S.B., Furumura, M., Dunn, K.J., Arnheiter, H. Pavan, W.J. (2000). Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum. Genet. 107, 1 6.
101. Potterf, S.B., Mollaaghababa, R., Hou, L., Southard-Smith, E.M., Hornyak, T.J., Arnheiter, H. Pavan, W.J. (2001). Analysis of SOX10 function in neural crest-derived melanocyte development: SOX10-dependent transcriptional control of dopachrome tautomerase. Dev. Biol. 237, 245 257.
102. Pusch, C., Hustert, E., Pfeifer, D., Sudbeck, P., Kist, R., Roe, B., Wang, Z., Balling, R., Blin, N. Scherer, G. (1998). The SOX10/Sox10 gene from human and mouse: sequence, expression, and transactivation by the encoded HMG domain transcription factor. Hum. Genet. 103, 115 123.
103. Qin, Y., Kong, L.K., Poirier, C., Truong, C., Overbeek, P.A. Bishop, C.E. (2004). Long-range activation of Sox9 in odd sex (Ods) mice. Hum. Mol. Genet. 13, 1213 1218.
104. Quevedo, W.C. Holstein, T.J. (2006). General biology of mammalian pigmentation. In The Pigmentary System, J.E.A., Nordland, ed
105. Rao, P., Fuller, G.N. Prieto, V.G. (2010). Expression of Sox-9 in metastatic melanoma-a potential diagnostic pitfall. Am. J. Dermatopathol. 32, 262 266.
106. Rehberg, S., Lischka, P., Glaser, G., Stamminger, T., Wegner, M. Rosorius, O. (2002). Sox10 is an active nucleocytoplasmic shuttle protein, and shuttling is crucial for Sox10-mediated transactivation. Mol. Cell. Biol. 22, 5826 5834.
107. Sanchez-Mejias, A., Watanabe, Y., R, M.F., Lopez-Alonso, M., Antinolo, G., Bondurand, N. Borrego, S. (2010). Involvement of SOX10 in the pathogenesis of Hirschsprung disease: report of a truncating mutation in an isolated patient. J. Mol. Med. 88, 507 514.
108. de Santa Barbara, P., Moniot, B., Poulat, F. Berta, P. (2000). Expression and subcellular localization of SF-1, SOX9, WT1, and AMH proteins during early human testicular development. Dev. Dyn. 217, 293 298.
109. Schepers, G.E., Teasdale, R.D. Koopman, P. (2002). Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev. Cell. 3, 167 170.
110. Schreiner, S., Cossais, F., Fischer, K., Scholz, S., Bosl, M.R., Holtmann, B., Sendtner, M. Wegner, M. (2007). Hypomorphic Sox10 alleles reveal novel protein functions and unravel developmental differences in glial lineages. Development 134, 3271 3281.
111. Serbedzija, G.N., Bronner-Fraser, M. Fraser, S.E. (1989). A vital dye analysis of the timing and pathways of avian trunk neural crest cell migration. Development 106, 809 816.
112. Serbedzija, G.N., Fraser, S.E. Bronner-Fraser, M. (1990). Pathways of trunk neural crest cell migration in the mouse embryo as revealed by vital dye labelling. Development 108, 605 612.
113. Sham, M.H., Lui, V.C., Chen, B.L., Fu, M. Tam, P.K. (2001). Novel mutations of SOX10 suggest a dominant negative role in Waardenburg-Shah syndrome. J. Med. Genet. 38, E30.
114. Sharov, A., Tobin, D.J., Sharova, T.Y., Atoyan, R. Botchkarev, V.A. (2005). Changes in different melanocyte populations during hair follicle involution (catagen). J. Invest. Dermatol. 125, 1259 1267.
115. Shimotake, T., Tanaka, S., Fukui, R., Makino, S. Maruyama, R. (2007). Neuroglial disorders of central and peripheral nervous systems in a patient with Hirschsprung's disease carrying allelic SOX10 truncating mutation. J. Pediatr. Surg. 42, 725 731.
116. Sinner, D., Kordich, J.J., Spence, J.R., Opoka, R., Rankin, S., Lin, S.C., Jonatan, D., Zorn, A.M. Wells, J.M. (2007). Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol. Cell. Biol. 27, 7802 7815.
117. Slominski, A. Paus, R. (1993). Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J. Invest. Dermatol. 101, 90S 97S.
118. Slominski, A., Paus, R. Costantino, R. (1991). Differential expression and activity of melanogenesis-related proteins during induced hair growth in mice. J. Invest. Dermatol. 96, 172 179.
119. Smit, D.J., Smith, A.G., Parsons, P.G., Muscat, G.E. Sturm, R.A. (2000). Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors. Eur. J. Biochem. 267, 6413 6422.
120. Smith, J.M. Koopman, P.A. (2004). The ins and outs of transcriptional control: nucleocytoplasmic shuttling in development and disease. Trends Genet. 20, 4 8.
121. Southard-Smith, E.M., Kos, L. Pavan, W.J. (1998). Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat. Genet. 18, 60 64.
122. Southard-Smith, E.M., Collins, J.E., Ellison, J.S., Smith, K.J., Baxevanis, A.D., Touchman, J.W., Green, E.D., Dunham, I. Pavan, W.J. (1999). Comparative analyses of the dominant megacolon-SOX10 genomic interval in mouse and human. Mamm. Genome 10, 744 749.
123. Spokony, R.F., Aoki, Y., Saint-Germain, N., Magner-Fink, E. Saint-Jeannet, J.P. (2002). The transcription factor Sox9 is required for cranial neural crest development in Xenopus. Development 129, 421 432.
124. Stanchina, L., Baral, V., Robert, F., Pingault, V., Lemort, N., Pachnis, V., Goossens, M. Bondurand, N. (2006). Interactions between Sox10, Edn3 and Ednrb during enteric nervous system and melanocyte development. Dev. Biol. 295, 232 249.
125. Stolt, C.C., Lommes, P., Hillgärtner, S. Wegner, M. (2008). The transcription factor Sox5 modulates Sox10 function during melanocyte development. Nucleic Acids Res. 36, 5427 5440.
126. Sviderskaya, E.V., Wakeling, W.F. Bennett, D.C. (1995). A cloned, immortal line of murine melanoblasts inducible to differentiate to melanocytes. Development 121, 1547 1557.
127. Sznajer, Y., Coldea, C., Meire, F., Delpierre, I., Sekhara, T. Touraine, R.L. (2008). A de novo SOX10 mutation causing severe type 4 Waardenburg syndrome without Hirschsprung disease. Am. J. Med. Genet. A. 146A, 1038 1041.
128. Taylor, K.M. LaBonne, C. (2005). SoxE factors function equivalently during neural crest and inner ear development and their activity is regulated by SUMOylation. Dev. Cell. 9, 593 603.
129. Thomas, A.J. Erickson, C.A. (2009). FOXD3 regulates the lineage switch between neural crest-derived glial cells and pigment cells by repressing MITF through a non-canonical mechanism. Development 136, 1849 1858.
130. Toki, F., Suzuki, N., Inoue, K., Suzuki, M., Hirakata, K., Nagai, K., Kuroiwa, M., Lupski, J.R. Tsuchida, Y. (2003). Intestinal aganglionosis associated with the Waardenburg syndrome: report of two cases and review of the literature. Pediatr. Surg. Int. 19, 725 728.
131. Topol, L., Chen, W., Song, H., Day, T.F. Yang, Y. (2009). Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J. Biol. Chem. 284, 3323 3333.
132. Touraine, R.L., Attie-Bitach, T., Manceau, E. et al. (2000). Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain. Am. J. Hum. Genet. 66, 1496 1503.
133. Verastegui, C., Bille, K., Ortonne, J.-P. Ballotti, R. (2000). Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10. J. Biol. Chem. 275, 30757 30760.
134. Verheij, J.B., Sival, D.A., van der Hoeven, J.H., Vos, Y.J., Meiners, L.C., Brouwer, O.F. van Essen, A.J. (2006). Shah-Waardenburg syndrome and PCWH associated with SOX10 mutations: a case report and review of the literature. Eur. J. Paediatr. Neurol. 10, 11 17.
135. Vinuela, A., Morin, M., Villamar, M., Morera, C., Lavilla, M.J., Cavalle, L., Moreno-Pelayo, M.A., Moreno, F. del Castillo, I. (2009). Genetic and phenotypic heterogeneity in two novel cases of Waardenburg syndrome type IV. Am. J. Med. Genet. A. 149A, 2296 2302.
136. Wegner, M. (2009). All purpose Sox: the many roles of Sox proteins in gene expression. Int. J. Biochem. Cell Biol. 42, 381 390.
137. Weiss, M.A. (2001). Floppy SOX: mutual induced fit in hmg (high-mobility group) box-DNA recognition. Mol. Endocrinol. 15, 353 362.
138. Werner, M.H. Burley, S.K. (1997). Architectural transcription factors: proteins that remodel DNA. Cell 88, 733 736.
139. Werner, M.H., Huth, J.R., Gronenborn, A.M. Clore, G.M. (1995). Molecular basis of human 46X,Y sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex. Cell 81, 705 714.
140. Werner, T., Hammer, A., Wahlbuhl, M., Bösl, M. R. Wegner, M. (2007). Multiple conserved regulatory elements with overlapping functions determine Sox10 expression in mouse embryogenesis. Nucleic Acids Res. 35, 6526 6538.
141. Wissmuller, S., Kosian, T., Wolf, M., Finzsch, M. Wegner, M. (2006). The high-mobility-group domain of Sox proteins interacts with DNA-binding domains of many transcription factors. Nucleic Acids Res. 34, 1735 1744.
142. Yan, Y.L., Willoughby, J., Liu, D., Crump, J.G., Wilson, C., Miller, C.T., Singer, A., Kimmel, C., Westerfield, M. Postlethwait, J.H. (2005). A pair of Sox: distinct and overlapping functions of zebrafish sox9 co-orthologs in craniofacial and pectoral fin development. Development 132, 1069 1083.
143. Yokoyama, S., Takeda, K. Shibahara, S. (2006). SOX10, in combination with Sp1, regulates the endothelin receptor type B gene in human melanocyte lineage cells. FEBS J. 273, 1805 1820.
144. Zhu, S., Wurdak, H., Wang, Y. et al. (2009a). A genomic screen identifies TYRO3 as a MITF regulator in melanoma. Proc. Natl. Acad. Sci. USA 106, 17025 17030.
145. Zhu, Y.T., Jia, Y., Hu, L., Qi, C., Prasad, M.K., McCallion, A.S. Zhu, Y.J. (2009b). PBP is essential for the growth of active Notch4-immortalized mammary epithelial cells by activating SOX10 expression. Biochem. J. 425, 435 444.